Melonga: Premature Ejaculation

Digital therapy for control

Free

Melonga is a clinically proven 12-week program for PE and better ejaculatory control. An access code is required. €169 full access, protected by a money-back guarantee. Melonga is a digital therapy program for the management of premature ejaculation. Access is limited to users for whom the program is considered appropriate. A personal access code is required to activate the app. A Structured Approach to Managing Premature Ejaculation Premature ejaculation is a common condition that can affect confidence, relationships, and overall well-being. Melonga™ is a structured digital therapy program designed to support the management of premature ejaculation through clinically informed behavioural training. Clinically Informed, Digital Delivery Melonga is based on behavioural approaches commonly used in clinical practice and translates them into a guided, structured digital program. The program is designed to support users in developing greater awareness, control, and confidence over time. Key Features -Structured 12-week program: A defined therapy pathway designed to support gradual improvement. - Behavioural training techniques: Exercises based on established clinical approaches. - Guided digital experience: Step-by-step modules to support consistent engagement. - Drug-free approach: Focuses on behavioural methods rather than pharmacological treatment. - Private and discreet: Designed for confidential use on a personal device. Intended Users Melonga may be suitable for adult men who: • Experience ejaculation sooner than desired • Are independent and self-motivated to follow a structured program • Prefer a non-pharmacological approach • Are seeking therapy options that value safety and privacy Melonga may not be appropriate for all users; therefore, access is limited. A personal access code is required to activate the app and can be requested after completing a short assessment and purchasing the program on our website. Privacy and Data Handling Melonga is designed with a strong emphasis on privacy. User data is handled securely within the EU with full GDPR compliance Important Information Melonga is a digital therapy program intended to support the management of premature ejaculation. It does not replace professional medical advice, diagnosis, or treatment. Users are advised to consult a qualified healthcare professional for medical concerns.

  • This app has not received enough ratings or reviews to display an overview.

The developer, Prognoix Health B.V., indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .

  • Data Linked to You

    The following data may be collected and linked to your identity:

    • Contact Info
    • User Content
    • Identifiers
  • Data Not Linked to You

    The following data may be collected but it is not linked to your identity:

    • User Content
    • Usage Data

Privacy practices may vary based, for example, on the features you use or your age. Learn More

The developer has not yet indicated which accessibility features this app supports. Learn More

Size
  • 45.7 MB
Category
  • Medical
Compatibility
Requires iOS 13.0 or later.
  • iPhone
    Requires iOS 13.0 or later.
  • iPad
    Requires iPadOS 13.0 or later.
  • iPod touch
    Requires iOS 13.0 or later.
Languages
  • English
Age Rating
18+
  • 18+
  • Frequent
    Mature or Suggestive Themes
    Medical Treatment Information

    Infrequent
    Profanity or Crude Humour
    Sexual Content or Nudity

    Contains
    Health or Wellness Topics
Provider
Prognoix Health B.V.
  • Prognoix Health B.V. has identified itself as a trader for this app and confirmed that this product or service complies with European Union law.
  • DUNS Number
    494477306
  • Address
    Oxfordlaan 55
    6229 EV Maastricht
    Netherlands
  • Phone Number
    +31 687875564
  • Email
    hello@prognoix.com
Medical Device
Yes
  • Prognoix Health B.V. indicated this app is a regulated medical device and complies with European Union law.
  • The information below has not been verified by Apple.
  • Manufacturer SRN
  • NL-MF-000036368
  • Address
  • Oxfordlaan 55
    6229 EV Maastricht
    Netherlands
  • Phone Number
  • +31 6 87875564
  • Email Address
  • admin.nl@prognoix.com
  • Use Statement
  • Melonga is intended to provide therapeutic techniques and exercises based on evidence-based psychoeducational and behavioral treatment methods appropriate for premature ejaculation patients of at least 18 years of age to assist them in managing their ejaculatory function. Melonga is intended for stand-alone use or as an adjunct to usual care to expand the psychosexual therapy options. The program may be used for a period of 12 weeks. Melonga is not intended to replace treatment by a healthcare provider, nor is it intended to provide information for diagnostic or therapeutic decisions.
  • Safety Information
  • No known contraindication and side-effects
  • Instructions for Use
  • Visit the developer site
Copyright
  • © 2026 Prognoix Health B.V.